# Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/respiratory-syncytial-virus-infection-developing-antiviral-drugs-for-prophylaxis-and-treatment-guidance-for-industry/59a11b52-4b6d-43c3-a5e2-4d57eedf16bc

> FDA guidance document: Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry. Issue date: October 11, 2017. Get complete insights and analysis.

---

## Details

- Title: Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-10-11
- Comment Close Date: 2017-12-11
- Last Changed: 2024-04-11

## Related Documents

- [Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/chronic-hepatitis-d-virus-infection-developing-drugs-for-treatment-guidance-for-industry/a162cb79-9621-497d-a34f-dd8e97dfa9b3)
- [Stimulant Use Disorders: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/stimulant-use-disorders-developing-drugs-for-treatment/396da81b-e089-444c-9781-b40a43a1cff2)
- [Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-gastroesophageal-reflux-disease-developing-drugs-for-treatment-guidance-for-industry/eed3bedd-c895-4ca2-bd44-b1c92b786f14)